New nano-pulse catheter aims to zap away heart rhythm problems
NCT ID NCT06696170
First seen Jan 12, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This study is testing a new device called the CellFX Nano-PFA 360 catheter, which uses very short electrical pulses to treat atrial fibrillation (an irregular heartbeat). About 60 adults aged 18 to 75 with paroxysmal atrial fibrillation will receive this treatment. The goal is to see if the device is safe and can successfully restore normal heart rhythm by blocking faulty electrical signals in the heart.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hartcentrum Hasselt Research Center /Jessa Hospital
ACTIVE_NOT_RECRUITINGHasselt, Belgium
-
Na Homolce Hospital
RECRUITINGPrague, Czechia
Contact
Contact
-
Policlinico Tor Vergata Hospital
RECRUITINGRoma, Italy
Contact
Contact
Conditions
Explore the condition pages connected to this study.